UNSPSC 51281618: Neomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H46N6O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I16QD7X297, more generally known as neomycin. European Medicines Agency schedules neomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03406MIG. The term NEOMYCIN is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 32, no 10 1978, list 18.

UNSPSC 51281618 Neomycin, a Commodity code, classifies pharmaceutical products for state and local procurement, though recent opportunities tagged under this code show limited direct alignment with neomycin specifically. State and local governments source pharmaceutical products — including antibiotics, opioid-antagonist medications, and related health supplies — through piggyback contracts with established statewide or regional purchasing consortia, competitive bidding processes for routine warehouse stock, and emergency-response procurement. The issuing bodies include state health departments (such as the Illinois Department of Public Health), county governments, and municipal health agencies. Purchases are typically framed as fixed-unit quantities with multi-year terms and renewal options, delivered on a quarterly or as-needed basis to centralized health facilities or distribution centers. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify enrollment, and appropriate insurance coverage. No explicit set-asides or disadvantaged-enterprise designations appear in the recent records.

Recent activity surfaces in Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (awarded August 28, 2026) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg under IFB 26-482DPH-PREPD-B-53392, covering a 12-month initial term with two optional renewal years. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building; the response deadline was July 26, 2023, and the contract included a two-year initial term with one-year renewal option. Neither opportunity directly names neomycin as a line item, suggesting the code's recent utilization in state and local procurement does not align closely with the neomycin commodity classification itself.